Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002638)

(Analysis AN004310)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14
FA(18:4)	ME625361	0.03	0.03	0.70	0.60	13.39	1.67	0.02	0.02	0.02	0.02	0.03	0.02	0.02	0.02
FA(14:1)	ME625351	0.45	0.38	0.90	0.89	7.83	1.48	0.65	0.40	0.36	0.27	2.38	0.45	0.34	0.29
hyodeoxycholate	ME625385	0.09	0.05	0.55	0.41	10.08	0.36	0.32	0.07	0.32	0.09	0.06	0.07	NA	0.04
FA(20:5(5Z,8Z,11Z,14Z,17Z)))	ME625370	0.23	0.23	1.20	1.00	7.86	3.26	0.18	0.16	0.18	0.17	0.23	0.19	0.21	0.19
cholate	ME625389	0.22	0.03	0.67	0.44	10.05	2.77	0.64	0.02	0.37	0.13	0.06	0.01	0.04	0.03
alpha-muricholate	ME625386	0.22	0.03	0.69	0.46	9.98	2.77	0.64	0.02	0.37	0.13	0.06	0.01	0.04	0.03
beta-muricholate	ME625387	0.22	0.03	0.69	0.45	10.00	2.77	0.64	0.02	0.37	0.13	0.06	0.01	0.04	0.03
omega-muricholate	ME625388	0.22	0.03	0.69	0.46	10.00	2.77	0.64	0.02	0.37	0.13	0.06	0.01	0.04	0.03
FA(12:0)	ME625344	0.89	1.18	2.44	1.32	1.31	0.81	0.59	0.50	2.51	0.34	0.81	0.22	0.21	0.83
FA(10:0-OH)	ME625340	0.67	0.77	2.26	2.02	1.18	0.48	0.60	0.59	0.68	0.62	0.60	0.56	0.66	0.80
FA(11:0-COOH)	ME625348	0.60	0.97	2.28	2.03	0.81	0.77	0.58	0.74	0.73	0.80	0.50	0.49	0.46	0.73
FA(8:0-OH)	ME625328	0.77	0.94	1.99	0.97	0.65	1.58	0.73	0.63	0.72	0.81	0.62	0.57	0.77	0.99
retinoate	ME625369	0.69	0.69	2.22	1.38	1.05	0.73	0.86	0.66	0.92	1.39	0.81	0.67	0.57	1.17
FA(8:0-COOH)	ME625334	0.83	0.99	1.69	0.89	1.03	1.12	0.91	0.95	0.91	0.92	0.82	0.86	0.85	0.96
FA(9:0-COOH)	ME625339	0.68	1.35	2.18	1.30	0.77	0.80	0.73	0.90	1.04	0.91	0.72	0.58	0.62	1.08
FA(10:0-COOH)	ME625345	0.77	1.15	1.83	1.18	0.73	0.81	0.90	0.91	1.11	0.78	0.86	0.76	0.84	1.07
FA(12:0-OH)	ME625349	0.89	0.99	2.20	1.09	0.98	0.76	0.77	0.87	1.04	0.73	0.86	0.63	0.75	0.94
3-hydroxybutyrate	ME625314	1.61	0.77	1.20	0.82	0.34	0.49	1.65	0.76	1.94	0.78	1.13	0.80	1.20	0.76
hydroxyindole acetate	ME625342	1.09	1.22	1.28	0.65	1.43	1.13	1.54	1.21	1.18	0.87	0.85	0.53	0.65	0.57
serine	ME625316	1.15	1.05	1.00	1.09	0.93	0.95	1.17	1.13	1.17	1.18	1.20	1.17	1.20	1.13
taurine	ME625320	1.14	1.14	1.07	1.07	0.98	1.12	1.16	1.16	1.13	1.11	1.13	1.07	1.08	1.05
FA(22:4)	ME625378	1.00	1.23	1.09	1.27	1.01	1.32	0.91	1.04	1.07	0.98	0.96	0.94	0.98	1.19
FA(18:0)	ME625366	0.92	1.03	1.18	1.15	1.19	1.18	1.15	0.99	1.06	1.10	1.09	1.07	0.98	1.05
FA(22:6(4Z,7Z,10Z,16Z,19Z))	ME625376	1.04	1.18	1.08	1.27	1.40	1.02	0.97	1.05	1.05	1.01	1.04	0.99	1.04	1.10
glutamine	ME625324	1.11	1.06	0.92	0.55	0.98	1.37	1.09	1.00	1.06	1.06	1.03	1.09	1.06	1.01
tyrosine	ME625336	1.01	1.12	1.01	0.69	1.03	1.22	1.07	0.98	0.99	0.97	1.01	1.03	1.01	1.11
histidine	ME625327	1.03	1.17	0.99	1.06	0.55	0.87	1.06	1.10	0.99	1.05	1.06	1.01	0.97	1.02
gamma-glutamylleucine	ME625358	1.07	1.27	0.97	0.70	0.66	0.81	1.15	1.11	1.13	1.07	1.16	1.05	1.10	1.22
phenylalanine	ME625330	1.03	1.28	1.08	0.61	0.68	0.90	1.06	1.14	1.12	1.11	1.08	1.12	1.02	1.19
cis-aconitate	ME625333	1.06	1.10	1.06	0.63	0.77	0.92	1.17	1.11	1.26	1.06	1.03	1.05	1.11	1.06
gamma-glutamylisoleucine	ME625357	0.98	1.29	1.14	0.62	0.70	0.84	1.23	1.15	1.25	1.02	1.08	1.00	1.01	1.07
2-hydroxybutyrate	ME625315	0.99	1.27	1.00	0.69	0.49	2.21	0.91	0.79	1.25	0.79	0.71	0.71	0.84	0.83
FA(14:0-OH)	ME625354	0.99	1.02	1.22	1.31	0.56	1.77	0.91	0.88	1.06	0.87	0.95	0.82	0.92	0.89
indoleacrylate	ME625338	0.98	0.98	0.96	1.13	0.52	1.37	0.99	0.84	1.13	0.88	1.03	0.92	0.94	0.90
tryptophan	ME625346	0.96	0.97	0.90	1.15	0.57	1.65	0.97	0.85	1.07	0.83	0.90	0.84	0.88	0.88
S-allylcysteine	ME625329	1.97	1.16	1.50	0.83	0.01	0.03	0.93	1.34	0.69	0.98	1.06	1.36	1.37	0.97
sphingosine-1P (C18)	ME625384	1.30	1.20	0.83	0.66	0.11	0.26	1.54	1.59	1.38	1.66	1.67	1.61	1.30	1.26
xanthosine	ME625365	1.09	1.68	0.96	1.10	0.18	0.20	0.91	1.17	1.07	0.94	1.02	0.99	1.27	1.65
AMP	ME625381	1.14	1.14	1.11	1.11	0.11	0.12	1.21	1.18	1.20	1.19	1.20	1.18	1.18	1.12
FA(20:4)	ME625371	1.15	1.20	1.15	1.23	0.60	0.65	1.15	1.16	1.19	1.16	1.17	1.17	1.18	1.19
aspartate	ME625322	1.11	1.08	1.05	1.02	0.42	0.46	1.20	1.08	1.18	1.11	1.18	1.13	1.07	1.12
glutamate	ME625326	1.09	1.13	1.00	1.04	0.48	0.38	1.14	1.15	1.15	1.14	1.16	1.13	1.11	1.14
maleate	ME625317	1.24	1.35	0.90	0.55	0.03	0.04	1.33	1.35	1.29	1.35	1.33	1.43	1.44	1.44
N-acetylphenylalanine	ME625347	1.03	1.41	1.03	0.50	0.29	0.45	1.19	1.29	1.13	1.30	1.32	1.23	1.23	1.40
hydroxyphenyllactic acid	ME625337	1.02	1.27	1.02	0.81	0.21	0.43	1.14	1.11	1.21	1.14	1.24	1.27	1.19	1.38
N-methylaspartate	ME625325	1.14	1.37	0.84	0.85	0.12	0.21	1.05	1.22	1.22	1.23	1.43	1.35	1.24	1.42
malate	ME625323	1.27	1.25	1.21	0.67	0.06	0.02	1.31	1.25	1.27	1.23	1.28	1.29	1.29	1.27
succinate	ME625318	1.19	1.31	1.19	0.64	0.24	0.22	1.20	1.29	1.18	1.20	1.23	1.21	1.22	1.31
citrate	ME625343	1.19	1.07	1.26	0.72	0.40	0.34	1.37	1.10	1.32	1.19	1.13	1.15	1.14	1.03
N-acetylleucine	ME625332	1.25	1.27	1.13	0.60	0.17	0.36	1.44	1.17	1.38	1.15	1.15	1.12	1.21	1.21
hippurate	ME625335	0.46	0.51	1.31	0.63	1.84	4.20	0.46	0.17	0.43	0.36	0.54	0.40	0.55	0.47
tauro-beta-muricholate	ME625390	0.59	1.61	0.69	0.44	0.43	3.73	0.99	0.67	0.33	1.08	0.55	0.70	0.22	1.05
tauro-alpha-muricholate + tauro-beta-muricholiate	ME625391	0.66	1.29	0.78	0.74	0.46	3.64	1.07	0.55	0.46	0.83	0.57	0.60	0.25	0.80
taurocholate	ME625393	0.77	1.23	0.84	0.86	0.35	3.69	1.28	0.40	0.58	0.64	0.74	0.40	0.22	0.49
tauro-alpha-muricholate	ME625392	0.83	0.83	0.93	0.88	1.66	2.85	1.45	0.35	0.73	0.52	0.80	0.40	0.40	0.55
FA(14:2)	ME625350	0.78	0.90	0.97	0.88	1.71	2.87	0.69	0.58	0.73	0.64	0.68	0.55	0.52	0.63
FA(22:0)	ME625380	0.59	0.72	1.22	1.11	2.11	2.76	0.79	0.80	0.56	0.67	0.86	0.66	0.49	0.66
FA(22:5)	ME625377	0.86	1.31	0.88	1.18	1.89	1.46	0.81	0.97	1.00	0.88	0.76	0.85	1.02	1.44
FA(16:0-OH)	ME625360	0.67	0.79	1.35	1.23	2.30	2.06	0.85	0.73	0.63	0.64	0.86	0.73	0.64	0.73
FA(16:0)	ME625356	0.83	0.94	1.19	1.16	2.07	1.70	0.92	0.87	0.85	0.88	0.92	0.85	0.82	0.89
FA(18:1)	ME625364	0.83	0.89	1.16	1.14	2.23	1.94	0.84	0.83	0.85	0.82	0.89	0.81	0.83	0.86
FA(16:0-COOH)	ME625367	0.84	0.85	1.48	0.88	1.53	2.30	0.76	0.77	1.29	0.64	0.68	0.67	0.71	0.74
lactate	ME625313	0.91	1.03	0.92	0.50	1.78	2.23	0.91	0.94	0.92	0.94	0.92	0.94	0.91	0.99
FA(15:0)	ME625353	0.52	0.44	1.41	1.12	2.74	2.54	1.05	0.54	0.33	0.28	2.30	0.70	0.37	0.32
FA(14:0)	ME625352	0.62	0.76	1.55	1.09	4.48	2.10	0.60	0.45	0.73	0.36	0.98	0.39	0.35	0.57
FA(16:1)	ME625355	0.47	0.51	1.48	1.35	4.42	2.42	0.57	0.42	0.40	0.32	1.08	0.43	0.36	0.41
FA(20:3)	ME625372	0.79	0.84	0.98	0.95	3.03	2.22	0.69	0.65	0.76	0.58	0.83	0.70	0.94	0.96
FA(17:0)	ME625359	0.50	0.63	1.39	1.10	3.29	2.50	0.78	0.55	0.55	0.55	1.24	0.63	0.46	0.56
FA(22:3)	ME625379	0.56	0.68	0.89	0.86	3.25	2.63	0.57	0.50	0.55	0.40	1.14	0.50	0.59	0.65
FA(20:0)	ME625375	0.38	0.58	1.30	0.85	2.98	3.86	0.68	0.49	0.48	0.55	0.63	0.49	0.34	0.48
FA(20:1)	ME625374	0.57	0.68	1.15	0.99	2.86	3.50	0.54	0.56	0.58	0.51	0.70	0.52	0.51	0.63
kynurenate	ME625341	0.51	0.68	0.92	0.72	3.53	3.20	0.39	0.37	0.47	0.37	0.36	0.36	0.63	0.95
threonine	ME625319	0.64	0.58	0.56	0.82	3.38	3.16	0.57	0.56	0.59	0.52	0.54	0.57	0.62	0.55
FA(18:2)	ME625363	0.08	0.09	0.93	0.65	5.80	5.63	0.12	0.08	0.07	0.07	0.30	0.09	0.07	0.08
FA(18:3)	ME625362	0.06	0.08	1.33	0.95	5.71	4.86	0.06	0.05	0.06	0.05	0.09	0.04	0.05	0.06
FA(24:0)	ME625383	0.30	0.42	0.61	0.56	4.73	4.77	0.42	0.52	0.30	0.27	0.45	0.33	0.25	0.32
FA(19:1)	ME625368	0.36	0.39	1.04	0.80	5.06	3.84	0.45	0.35	0.30	0.28	1.07	0.37	0.28	0.33
FA(20:2)	ME625373	0.35	0.44	1.13	0.89	4.57	3.98	0.38	0.34	0.34	0.31	0.65	0.34	0.35	0.42
ketoleucine	ME625321	0.22	0.33	0.76	0.30	0.78	6.80	0.23	0.31	0.21	0.24	0.31	0.36	0.28	0.23
FA(24:1)	ME625382	0.19	0.24	0.37	0.37	2.63	7.41	0.26	0.24	0.22	0.23	0.34	0.24	0.18	0.25
urate	ME625331	0.33	0.26	0.62	0.40	2.37	5.76	0.41	0.22	0.38	0.29	0.40	0.22	0.32	0.33

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-DriftCorrection \| Timepoint:0 hour \| Sex:-
F4	Group:QC-Pooled \| Timepoint:0 hour \| Sex:-
F5	Group:QC-ReCAS \| Timepoint:0 hour \| Sex:-
F6	Group:QC-Reference \| Timepoint:0 hour \| Sex:-
F7	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F8	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F9	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F10	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F11	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F12	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F13	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F14	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix